153 related articles for article (PubMed ID: 3542453)
1. Effects of mixing short- and intermediate-acting insulins on absorption course and biologic effect of short-acting preparation.
Forlani G; Santacroce G; Ciavarella A; Capelli M; Mattioli L; Vannini P
Diabetes Care; 1986; 9(6):587-90. PubMed ID: 3542453
[TBL] [Abstract][Full Text] [Related]
2. Mixtures of human intermediate and human regular insulin in type 1 diabetic patients. Evaluation of free insulin levels and insulin action on glucose metabolism after combined and separate subcutaneous administration.
Klauser R; Schernthaner G; Prager R
Diabetes Res Clin Pract; 1988 Sep; 5(3):185-90. PubMed ID: 3065016
[TBL] [Abstract][Full Text] [Related]
3. The clinical effects of mixing short- and intermediate-acting insulins in the treatment of non-insulin-dependent diabetes.
Best JD; Ley CJ; Strauss BJ; Alford FP; Aitken PM
Med J Aust; 1987 Jun; 146(12):621-3, 627. PubMed ID: 3306298
[TBL] [Abstract][Full Text] [Related]
4. Miscibility of human semisynthetic regular and lente insulin and human biosynthetic regular and NPH insulin.
Olsson PO; Hans A; Henning VS
Diabetes Care; 1987; 10(4):473-7. PubMed ID: 3304898
[TBL] [Abstract][Full Text] [Related]
5. Assessing effect of mixing insulins by glucose-clamp technique in subjects with diabetes mellitus.
Colagiuri S; Villalobos S
Diabetes Care; 1986; 9(6):579-86. PubMed ID: 3542452
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors.
Hildebrandt P
Dan Med Bull; 1991 Aug; 38(4):337-46. PubMed ID: 1914533
[TBL] [Abstract][Full Text] [Related]
7. Mixing short and intermediate acting insulins in the syringe: effect on postprandial blood glucose concentrations in type I diabetics.
Heine RJ; Bilo HJ; Sikkenk AC; van der Veen EA
Br Med J (Clin Res Ed); 1985 Jan; 290(6463):204-5. PubMed ID: 3917752
[No Abstract] [Full Text] [Related]
8. [Studies on the absorption kinetics of subcutaneously administered insulin].
Misawa K
Hokkaido Igaku Zasshi; 1989 Nov; 64(6):792-812. PubMed ID: 2691384
[TBL] [Abstract][Full Text] [Related]
9. Comparison of blood glucose profile and glycemic control in type 1 diabetic patients treated with Actrapid-Monotard or Actrapid Protaphane (NPH) human insulins.
Buysschaert M; Minette P; Ketelslegers JM; Pairet JV; Vogels M; Lambert AE
Diabetes Res; 1987 Jan; 4(1):31-3. PubMed ID: 3552364
[TBL] [Abstract][Full Text] [Related]
10. Absorption kinetics and biologic effects of subcutaneously injected insulin preparations.
Berger M; Cüppers HJ; Hegner H; Jörgens V; Berchtold P
Diabetes Care; 1982; 5(2):77-91. PubMed ID: 6765510
[TBL] [Abstract][Full Text] [Related]
11. The effect of insulin mixtures in type I diabetics: influence of the intermediate acting insulin on the action of short acting insulin.
Goicolea I; Quiroga A; Vazquez JA
Diabete Metab; 1987; 13(4):467-70. PubMed ID: 3315768
[TBL] [Abstract][Full Text] [Related]
12. The effect of mixing regular- and intermediate-acting insulins on their absorption and biological activity.
Schulz B; Menzel R; Besch W
Exp Clin Endocrinol; 1988 Mar; 91(1):27-34. PubMed ID: 3286272
[TBL] [Abstract][Full Text] [Related]
13. Absorption kinetics and action profiles of mixtures of short- and intermediate-acting insulins.
Heine RJ; Bilo HJ; Fonk T; van der Veen EA; van der Meer J
Diabetologia; 1984 Dec; 27(6):558-62. PubMed ID: 6397384
[TBL] [Abstract][Full Text] [Related]
14. Effects of the anatomical region used for insulin injections on glycemia in type I diabetes subjects.
Bantle JP; Neal L; Frankamp LM
Diabetes Care; 1993 Dec; 16(12):1592-7. PubMed ID: 8299455
[TBL] [Abstract][Full Text] [Related]
15. Stability and reproducibility of the biologic activity of premixed short-acting and intermediate-acting insulins.
Jawadi MH; Ho LS
Am J Med; 1986 Sep; 81(3):467-71. PubMed ID: 3529954
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous use of regular human insulin (Novo): pharmacokinetics and continuous insulin infusion therapy.
Sonnenberg GE; Kemmer FW; Cüppers HJ; Berger M
Diabetes Care; 1983; 6 Suppl 1():35-9. PubMed ID: 6343035
[TBL] [Abstract][Full Text] [Related]
17. Assessment of diabetic control with Actrapid and Monotard insulins.
Harrower AD; Archibald L
Practitioner; 1980 Jun; 224(1344):657-8. PubMed ID: 6999491
[No Abstract] [Full Text] [Related]
18. The absorption of subcutaneously injected short-acting soluble insulin: influence of injection technique and concentration.
Hildebrandt P; Sestoft L; Nielsen SL
Diabetes Care; 1983; 6(5):459-62. PubMed ID: 6400706
[TBL] [Abstract][Full Text] [Related]
19. The effect of mixing human soluble and human crystalline zinc-suspension insulin: plasma insulin and blood glucose profiles after subcutaneous injection.
Francis AJ; Hanning I; Alberti KG
Diabet Med; 1985 May; 2(3):177-80. PubMed ID: 2952414
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous injection with an insulin pen. Insulin absorption and plasma concentrations of glucose and free insulin.
de Meijer PH; Lutterman JA
Neth J Med; 1990 Feb; 36(1-2):4-12. PubMed ID: 2179752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
